# Namil General Foods Co. · 16-120 · KOREA (THE REPUBLIC OF) — FDA import alert red lists: firms subject to detention without physical examination

For Namil General Foods Co. · 16-120 · KOREA (THE REPUBLIC OF), import alert is 16-120; import alert name is "Detention Without Physical Examination of ***Fish and Fishery*** Products from Foreign Processors (Mfrs.) Not in Compliance with Seafood HACCP ***Regulation***"; country is KOREA (THE REPUBLIC OF); product is RTE LACF Kimchi and Pacific Saury | RTE LACF Pacific Saury (Mackerel Pike) | RTE LACF Pacific Saury (Mackerel Pike) | RTE LACF Kimchi and Pacific Saury | RTE LACF Mackerel | RTE LACF Kimchi and Pacific Saury | RTE LACF Pacific Saury (Mackerel Pike) | RTE LACF Kimchi and Pacific Saury; product code is 16 A - - 21 Herring | 16 A - - 21 Herring | 16 A - - 22 Mackerel (only Scomberomorus spp eg. Spanish or King) | 16 A - - 22 Mackerel (only Scomberomorus spp eg. Spanish or King) | 16 A - - 73 Mackerel (all except Scomberomorus sp, eg Spanish or King see '22') | 16 A - - 73 Mackerel (all except Scomberomorus sp, eg Spanish or King see '22') | 16 A - - 76 Saury | 16 A - - 76 Saury; date published is 09/03/2025; address is 20 Jangpyeongro132beon-Gil , Saha District, Busan KOREA (THE REPUBLIC OF), verified against its source on 2026-09-16.

- **Firm:** Namil General Foods Co. _(verified: appears in the quote below)_
- **Import alert:** 16-120
- **Import alert name:** "Detention Without Physical Examination of ***Fish and Fishery*** Products from Foreign Processors (Mfrs.) Not in Compliance with Seafood HACCP ***Regulation***"
- **Country:** KOREA (THE REPUBLIC OF) _(verified: appears in the quote below)_
- **Address:** 20 Jangpyeongro132beon-Gil , Saha District, Busan KOREA (THE REPUBLIC OF) _(verified: appears in the quote below)_
- **Date published:** 09/03/2025 _(verified: appears in the quote below)_
- **Product code:** 16 A - - 21 Herring | 16 A - - 21 Herring | 16 A - - 22 Mackerel (only Scomberomorus spp eg. Spanish or King) | 16 A - - 22 Mackerel (only Scomberomorus spp eg. Spanish or King) | 16 A - - 73 Mackerel (all except Scomberomorus sp, eg Spanish or King see '22') | 16 A - - 73 Mackerel (all except Scomberomorus sp, eg Spanish or King see '22') | 16 A - - 76 Saury | 16 A - - 76 Saury _(verified: each item appears in the quote below)_
- **Product:** RTE LACF Kimchi and Pacific Saury | RTE LACF Pacific Saury (Mackerel Pike) | RTE LACF Pacific Saury (Mackerel Pike) | RTE LACF Kimchi and Pacific Saury | RTE LACF Mackerel | RTE LACF Kimchi and Pacific Saury | RTE LACF Pacific Saury (Mackerel Pike) | RTE LACF Kimchi and Pacific Saury _(verified: each item appears in the quote below)_
- **FDA notes:** HACCP violations. FDA inspection of this food manufacturing facility found serious deviations of the seafood HACCP regulations (21 CFR Part 123). Based on FDA’s inspectional findings and review of the firm’s response, the FDA determined that the firm’s LACF Pacific Saury, LACF Mackerel, and LACF Kimchi and Pacific Saury products processed in the facility appear to be adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act. Specific violations include: 21 CFR 123.6(c)- The firm does not have a HACCP plan to control the hazards of Scombrotoxin (Histamine) formation and undeclared food allergens. | HACCP violations. FDA inspection of this food manufacturing facility found serious deviations of the seafood HACCP regulations (21 CFR Part 123). Based on FDA’s inspectional findings and review of the firm’s response, the FDA determined that the firm’s LACF Pacific Saury, LACF Mackerel, and LACF Kimchi and Pacific Saury products processed in the facility appear to be adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act. Specific violations include: 21 CFR 123.6(c)- The firm does not have a HACCP plan to control the hazards of Scombrotoxin (Histamine) formation and undeclared food allergens. | HACCP violations. FDA inspection of this food manufacturing facility found serious deviations of the seafood HACCP regulations (21 CFR Part 123). Based on FDA’s inspectional findings and review of the firm’s response, the FDA determined that the firm’s LACF Pacific Saury, LACF Mackerel, and LACF Kimchi and Pacific Saury products processed in the facility appear to be adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act. Specific violations include: 21 CFR 123.6(c)- The firm does not have a HACCP plan to control the hazards of Scombrotoxin (Histamine) formation and undeclared food allergens. | HACCP violations. FDA inspection of this food manufacturing facility found serious deviations of the seafood HACCP regulations (21 CFR Part 123). Based on FDA’s inspectional findings and review of the firm’s response, the FDA determined that the firm’s LACF Pacific Saury, LACF Mackerel, and LACF Kimchi and Pacific Saury products processed in the facility appear to be adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act. Specific violations include: 21 CFR 123.6(c)- The firm does not have a HACCP plan to control the hazards of Scombrotoxin (Histamine) formation and undeclared food allergens. | HACCP violations. FDA inspection of this food manufacturing facility found serious deviations of the seafood HACCP regulations (21 CFR Part 123). Based on FDA’s inspectional findings and review of the firm’s response, the FDA determined that the firm’s LACF Pacific Saury, LACF Mackerel, and LACF Kimchi and Pacific Saury products processed in the facility appear to be adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act. Specific violations include: 21 CFR 123.6(c)- The firm does not have a HACCP plan to control the hazards of Scombrotoxin (Histamine) formation and undeclared food allergens. | HACCP violations. FDA inspection of this food manufacturing facility found serious deviations of the seafood HACCP regulations (21 CFR Part 123). Based on FDA’s inspectional findings and review of the firm’s response, the FDA determined that the firm’s LACF Pacific Saury, LACF Mackerel, and LACF Kimchi and Pacific Saury products processed in the facility appear to be adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act. Specific violations include: 21 CFR 123.6(c)- The firm does not have a HACCP plan to control the hazards of Scombrotoxin (Histamine) formation and undeclared food allergens. | HACCP violations. FDA inspection of this food manufacturing facility found serious deviations of the seafood HACCP regulations (21 CFR Part 123). Based on FDA’s inspectional findings and review of the firm’s response, the FDA determined that the firm’s LACF Pacific Saury, LACF Mackerel, and LACF Kimchi and Pacific Saury products processed in the facility appear to be adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act. Specific violations include: 21 CFR 123.6(c)- The firm does not have a HACCP plan to control the hazards of Scombrotoxin (Histamine) formation and undeclared food allergens. | HACCP violations. FDA inspection of this food manufacturing facility found serious deviations of the seafood HACCP regulations (21 CFR Part 123). Based on FDA’s inspectional findings and review of the firm’s response, the FDA determined that the firm’s LACF Pacific Saury, LACF Mackerel, and LACF Kimchi and Pacific Saury products processed in the facility appear to be adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act. Specific violations include: 21 CFR 123.6(c)- The firm does not have a HACCP plan to control the hazards of Scombrotoxin (Histamine) formation and undeclared food allergens. _(verified: each item appears in the quote below)_

## What the source says

> Namil General Foods Co. Date Published : 09/03/2025 20 Jangpyeongro132beon-Gil , Saha District, Busan KOREA (THE REPUBLIC OF) 16 A - - 21 Herring Date Published: 09/03/2025 Desc: RTE LACF Kimchi and Pacific Saury Notes: HACCP violations. FDA inspection of this food manufacturing facility found serious deviations of the seafood HACCP regulations (21 CFR Part 123). Based on FDA’s inspectional findings and review of the firm’s response, the FDA determined that the firm’s LACF Pacific Saury, LACF Mackerel, and LACF Kimchi and Pacific Saury products processed in the facility appear to be adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act. Specific violations include: 21 CFR 123.6(c)- The firm does not have a HACCP plan to control the hazards of Scombrotoxin (Histamine) formation and undeclared food allergens. 16 A - - 21 Herring Date Published: 09/03/2025 Desc: RTE LACF Pacific Saury (Mackerel Pike) Notes: HACCP violations. FDA inspection of this food manufacturing facility found serious deviations of the seafood HACCP regulations (21 CFR Part 123). Based on FDA’s inspectional findings and review of the firm’s response, the FDA determined that the firm’s LACF Pacific Saury, LACF Mackerel, and LACF Kimchi and Pacific Saury products processed in the facility appear to be adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act. Specific violations include: 21 CFR 123.6(c)- The firm does not have a HACCP plan to control the hazards of Scombrotoxin (Histamine) formation and undeclared food allergens. 16 A - - 22 Mackerel (only Scomberomorus spp eg. Spanish or King) Date Published: 09/03/2025 Desc: RTE LACF Pacific Saury (Mackerel Pike) Notes: HACCP violations. FDA inspection of this food manufacturing facility found serious deviations of the seafood HACCP regulations (21 CFR Part 123). Based on FDA’s inspectional findings and review of the firm’s response, the FDA determined that the firm’s LACF Pacific Saury, LACF Mackerel, and LACF Kimchi and Pacific Saury products processed in the facility appear to be adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act. Specific violations include: 21 CFR 123.6(c)- The firm does not have a HACCP plan to control the hazards of Scombrotoxin (Histamine) formation and undeclared food allergens. 16 A - - 22 Mackerel (only Scomberomorus spp eg. Spanish or King) Date Published: 09/03/2025 Desc: RTE LACF Kimchi and Pacific Saury Notes: HACCP violations. FDA inspection of this food manufacturing facility found serious deviations of the seafood HACCP regulations (21 CFR Part 123). Based on FDA’s inspectional findings and review of the firm’s response, the FDA determined that the firm’s LACF Pacific Saury, LACF Mackerel, and LACF Kimchi and Pacific Saury products processed in the facility appear to be adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act. Specific violations include: 21 CFR 123.6(c)- The firm does not have a HACCP plan to control the hazards of Scombrotoxin (Histamine) formation and undeclared food allergens. 16 A - - 73 Mackerel (all except Scomberomorus sp, eg Spanish or King see '22') Date Published: 09/03/2025 Desc: RTE LACF Mackerel Notes: HACCP violations. FDA inspection of this food manufacturing facility found serious deviations of the seafood HACCP regulations (21 CFR Part 123). Based on FDA’s inspectional findings and review of the firm’s response, the FDA determined that the firm’s LACF Pacific Saury, LACF Mackerel, and LACF Kimchi and Pacific Saury products processed in the facility appear to be adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act. Specific violations include: 21 CFR 123.6(c)- The firm does not have a HACCP plan to control the hazards of Scombrotoxin (Histamine) formation and undeclared food allergens. 16 A - - 73 Mackerel (all except Scomberomorus sp, eg Spanish or King see '22') Date Published: 09/03/2025 Desc: RTE LACF Kimchi and Pacific Saury Notes: HACCP violations. FDA inspection of this food manufacturing facility found serious deviations of the seafood HACCP regulations (21 CFR Part 123). Based on FDA’s inspectional findings and review of the firm’s response, the FDA determined that the firm’s LACF Pacific Saury, LACF Mackerel, and LACF Kimchi and Pacific Saury products processed in the facility appear to be adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act. Specific violations include: 21 CFR 123.6(c)- The firm does not have a HACCP plan to control the hazards of Scombrotoxin (Histamine) formation and undeclared food allergens. 16 A - - 76 Saury Date Published: 09/03/2025 Desc: RTE LACF Pacific Saury (Mackerel Pike) Notes: HACCP violations. FDA inspection of this food manufacturing facility found serious deviations of the seafood HACCP regulations (21 CFR Part 123). Based on FDA’s inspectional findings and review of the firm’s response, the FDA determined that the firm’s LACF Pacific Saury, LACF Mackerel, and LACF Kimchi and Pacific Saury products processed in the facility appear to be adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act. Specific violations include: 21 CFR 123.6(c)- The firm does not have a HACCP plan to control the hazards of Scombrotoxin (Histamine) formation and undeclared food allergens. 16 A - - 76 Saury Date Published: 09/03/2025 Desc: RTE LACF Kimchi and Pacific Saury Notes: HACCP violations. FDA inspection of this food manufacturing facility found serious deviations of the seafood HACCP regulations (21 CFR Part 123). Based on FDA’s inspectional findings and review of the firm’s response, the FDA determined that the firm’s LACF Pacific Saury, LACF Mackerel, and LACF Kimchi and Pacific Saury products processed in the facility appear to be adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act. Specific violations include: 21 CFR 123.6(c)- The firm does not have a HACCP plan to control the hazards of Scombrotoxin (Histamine) formation and undeclared food allergens.

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_25.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).